Tilray Brands, Inc.

US$2.92As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TLRYHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (52.45%)
Div yield —
ROE (9.38%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.06
PE TTM —
TSR TTM (78.21%)
Mkt cap US$428.3M
ROIC (3.29%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.45
17.99%
(62.35%)
Hold 2|11|2|8|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.07
0.06
0.06
0.07
20.34%
8.97%
12.24%
7.79%
Revenue$M
20.97
21.15
22.02
21.80
(7.25%)
(4.65%)
0.42%
1.78%
Peers (US$428.3M)
Cap (US$)
PE
342.6M
—
428.3M
49.33x
Capital
TTM
5Y
10Y
Leveragex
0.384
(0.238)
(0.173)
EBIT/Intx
1.316
0.787
0.838
Own earn%
(299.87)
20.08
18.12
Sh yield%
31.29
21.22
20.98
Owners
Insiders/Inst%
10.20
82.67
Short interest%
3.75
SBC / revenue%
5.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
13–21
$1 testx
—
Incr. ROIC%
2